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Case report Pituitary hCG production and cerebral tuberculosis 
mimicking disease progression during 
chemotherapy for an advanced ovarian germ cell 
tumour
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Abstract
Background: Ovarian germ cell tumours (OGCT) are rare but are usually curable with chemotherapy, even when 
presenting with advanced disease. The majority of OGCT produce the tumour markers, hCG and/or AFP which can be 
helpful in the diagnosis and monitoring the response to treatment.
Case Presentation: In this case of a 36 year old woman, the elevated hCG level at presentation was helpful in making 
a clinical diagnosis of OGCT in a patient too unwell to permit a tissue diagnosis.
Cisplatin based combination chemotherapy produced an initial normalisation of the hCG level, but later in treatment
the patient developed new cerebral lesions and a rising serum hCG suggestive of disease progression.
Further investigations suggested that the CNS lesions were cerebral TB and that the low levels of hCG elevations was
likely to be pituitary in origin. Chemotherapy treatment was continued along with anti-tuberculous therapy and 24
months after successful completion of therapy the patient remains disease free.
Conclusions: In the treatment of cancer patients it may be helpful to consider the potential non-malignant causes of 
new CNS lesions and that low hCG elevations may result from physiology rather than pathology in selected cases.
Background
The diagnosis of a malignant ovarian germ cell tumour is
rare with less than 100 new cases per year in the UK. For
patients with advanced disease treatment with cisplatin
based chemotherapy is generally curative with the overall
cure rates approaching 80% [1]. Elevated tumour marker
levels can be helpful in establishing the diagnosis in
patients with advanced germ cell tumours as approxi-
mately 85% of cases of OGCT make one or both of the
tumour markers hCG and AFP, with a poorer prognosis
for those producing both at presentation [1]. During che-
motherapy treatment the rate of the fall of the tumour
markers can be helpful in assessing response and a failure
to fall appropriately or to rise on treatment is associated
with a poor outcome [2].
Tuberculosis remains a major public health issue
worldwide and is currently increasing in incidence in the
developed world. The reactivation of previously dormant
TB in patients treated with steroids [3] or with chemo-
therapy is well documented [4], however the co-existence
of TB in a patient with a malignancy is relatively unusual
in developed countries with estimated TB incidence rates
of 1:500-1:1000 cancer patients and most clinicians will
see few if any cases [5].
In addition to production in pregnancy, trophoblast
tumours and ovarian germ cell tumours, the production
of low levels of hCG from the pituitary gland in post
menopausal women has recently been documented. This
physiological production of hCG has previously lead to
diagnostic confusion in patients who were presumed to
have occult gestational tumours and went on to receive
unwarranted treatment [6].
A similar situation of physiological pituitary hCG pro-
duction can occur in women receiving treatment for hCG
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producing malignancies. As a result of the ovarian sup-
pression induced initially by the high hCG levels and then
by their chemotherapy, these women can develop low
oestrogen levels and a pattern of elevated LH, FSH and
o c c a s i o n a l l y  h C G  l e v e l s  s i m i l a r  t o  t h a t  s e e n  i n  p o s t
menopausal women.
Case presentation
A 36 year old woman was admitted to her local hospital
following a collapse at work, she had a 3 month history of
dyspnoea, weight loss and abdominal swelling.
Clinical examination demonstrated a large mass occu-
pying most of the abdomen and pelvis which was con-
firmed on CT scanning as shown in Fig 1. Additionally
there were bilateral pleural effusions, but no other appar-
ent pulmonary abnormalities. A CT scan of the brain
showed no apparent abnormalities.
The routine haematology and biochemistry blood tests
were unremarkable, however the serum hCG level was
elevated at 1322 IU/L (nr 0-4), the CA-125 was also ele-
vated at 1475 U/ml, whilst the serum AFP level was nor-
mal.
The clinical diagnosis made was of an advanced malig-
nant ovarian germ cell tumour and shortly after transfer
the patient's condition worsened with bowel obstruction
and a pneumothorax in addition to the bilateral pleural
effusions. This difficult clinical situation mandated rapid
treatment and urgent chemotherapy was commenced
with two days of etoposide (100 mg/m2) and cisplatin (20
mg/m2) using dexamethasone and ondansetron as the
anti-emetics. The initiation of chemotherapy lead to a
significant improvement in the clinical condition and the
chemotherapy regimen was then changed to the POMB/
ACE combination [7].
Following a brief stay in ITU for the treatment of
hypotension and neutropaenic sepsis the patient was dis-
charged home 1 month after admission to continue out-
patient based chemotherapy with the hCG falling to
normal 6 weeks after commencing treatment.
Two weeks after hospital discharge, the patient repre-
sented with a short history of impaired consciousness
and pyrexia. Investigations demonstrated neutropaenia
and hypokalaemia but with a normal CT scan of the brain
and normal serum hCG levels.
At this point the diagnosis was unclear and the patient
received empirical treatment for neutropaenic sepsis,
viral encephalitis and tuberculosis. Two days later the
patient's condition deteriorated further with the develop-
ment of meningism and nystagmus and an MRI scan of
the brain demonstrated oedema and a number of enhanc-
ing lesions reported as probable metastases as shown in
Fig 2.
The empirical emergency treatment was continued
with antibiotics, anti-virals, steroids and anti-TB therapy
comprising Rifater, Pyridoxine, and Ethambutol and over
the next 10 days the patient's condition improved gradu-
ally. The CSF sample taken at readmission was reported
as positive for TB by both PCR and Elispot and culture
positive growth was subsequently seen at 21 days.
Following the improvement from the acute neurologi-
cal events, the POMB/ACE chemotherapy was recom-
menced but at this point the serum hCG level had
Figure 1 CT scan of the abdomen on admission. This scan demon-
strates a large necrotic, partially cystic tumour occupying most of the 
abdomen. The CT scan also demonstrated marked paraaortic lymph-
adenopathy but no visceral or CNS metastases.
Figure 2 MRI brain scan performed mid-treatment. The MRI brain 
scan performed shortly after readmission with acute neurological 
symptoms, demonstrates a number of ring-enhancing lesions with 
surrounding oedema which were thought likely to be metastases.Rakha et al. BMC Cancer 2010, 10:338
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become elevated with values ranging from 5-10 IU/L and
this finding combined with an initial increase in the size
and number of the CNS lesions on a repeat MRI again
raised the concern that at least some of the lesions could
be CNS metastases. However with the diagnosis of CNS
TB confirmed and our previous experienced of transient
hCG elevations in women treated with prolonged chemo-
therapy we elected to assume that all the lesions were
infective in origin and persist with the chemotherapy
treatment as planned.
The POMB/ACE chemotherapy was concluded with a
total of 16 weeks treatment, whilst the anti-TB therapy
was continued for a full course of 6 months. During the
remainder of chemotherapy and initially post treatment
the hCG level remained elevated for approximately 3
months before returning to the normal range as shown in
the treatment graph in Fig 3.
At the completion of chemotherapy, a laparotomy was
performed, removing the residual tumour, the ovarian
remnant, but leaving the uterus and contralateral ovary in
place. The pathology from the resected tumour was
reported as necrotic tissue in keeping with a germ cell
origin but without any viable tumour.
Post operatively the patient made an excellent returning
to work 9 months after presentation with normal men-
strual function returning 8 months after finishing chemo-
therapy. The follow up investigations have confirmed that
the abdomen and pelvis remain free of disease and the
CNS lesions have essentially resolved, as shown in Fig 4,
and the hCG levels remain normal.
Conclusions
Ovarian germ cell tumours characteristically occur in
teenagers and young women and as a result of their rapid
growth can present at advanced stages with clinically
unwell patients.
From choice the diagnosis of OGCT should be con-
firmed histologically, either from oopherectomy in low
stage disease or by biopsy in advanced disease. However
in patients who are too unwell to tolerate an invasive pro-
cedure or the delay in confirming the diagnosis, then
emergency treatment based on the likely clinical diagno-
sis can be warranted. In this case report the production of
hCG by the tumour aided the clinical diagnosis pointing
towards either a gestational tumour or an ovarian germ
cell tumour as the most likely diagnoses. The relatively
low level of hCG compared to the large bulk of the
tumour favoured the diagnosis of an OGCT as the levels
of expression can vary more widely in this diagnosis than
in a gestational tumour and rarely reach very high levels.
Chemotherapy treatment leads to cure in the majority
of patients with advanced OGCT, however in those with
Figure 3 hCG treatment graph. This demonstrates the level of the serum hCG and the timing of chemotherapy treatment. After the initial elevation 
and fall to normal there was a 3 month low level hCG elevation. The solid line indicates the lower level of detection of the assay (1 IU/L) the dashed 
line the upper limit of the normal range (0-4 IU/L).Rakha et al. BMC Cancer 2010, 10:338
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treatment resistance and particularly progression on
therapy as generally displayed by rising markers or the
development of new lesions the prognosis is poor. The
group of GCT patients with the worst prognosis are those
who develop CNS on treatment, for this group further
chemotherapy treatment is rarely productive [8]. Fortu-
nately in this case the developing CNS lesions were indi-
cated as likely cerebral TB by PCR and Elispot analysis,
and successfully treated with combination anti-tubercu-
lous therapy. Alongside this the POMB/ACE chemother-
apy was continued and has almost certainly cured the
patient of the tumour.
A number of previous publications have highlighted the
possibility of reactivation of TB occurring as a result of
steroids or chemotherapy-induced immunosuppression
[3-5], by far the most frequent sites of TB activity is in the
lungs and it is extremely unusual for TB to present in the
CNS without evidence of the disease elsewhere.
Generally hCG measurements give an accurate insight
into the response of gestational and germ cell tumours to
treatment with a very low incidence of false positive ele-
vations. Recently it has been observed that modest eleva-
tions of hCG of pituitary origin can also occur of a part of
normal physiology in post menopausal women in parallel
with the high levels of LH and FSH produced [6]. A simi-
lar picture of presumed pituitary hCG production
appears to take place in some women who have low
oestrogen levels from inhibited ovarian function gener-
ally from prolonged chemotherapy and in this case report
the patient had report a 6 month history of amenorrhea
prior to starting chemotherapy that would have lead to
low oestrogen levels at the start of treatment.
Whilst new CNS lesions and rising tumour marker lev-
els would generally suggest metastasis and signify cancer
progression, this case illustrates that there are differential
diagnoses of both findings and very occasionally both will
be due to non-malignant causes. In this unusual case che-
motherapy was successfully continued, despite these con-
cerning findings, and will probably have resulted in the
cure of the patient.
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Figure 4 MRI brain scan performed 9 months post chemotherapy. 
The follow-up scan indicates that the previously noted oedema and 
the majority of the CNS lesions have resolved.Rakha et al. BMC Cancer 2010, 10:338
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